Tennessee Access Score: 36/100
Composite of methadone OTP density, buprenorphine provider density, mental health shortage need-met %, Medicaid coverage breadth, 1115 SUD waiver status, and legal protections. How we score.
Tennessee has 22 currently SAMHSA-certified opioid treatment programs across 16 cities. Methadone is dispensed daily on-site at OTPs, which is the regulatory boundary that defines this list.
Composite analysis
Tennessee sits in the top quarter of states for treatment access pressure. Demand signals are elevated and verified provider supply is thin relative to population.
TAPI is a CCIWA composite. Each input is z-scored across 50 states plus DC and Puerto Rico, then combined as a weighted sum (HPSA 30%, frequent mental distress 25%, unemployment 15%, treatment density 30%, sign-flipped). The result is rescaled 0 to 100 by percentile rank. Read the full methodology.
Composite of methadone OTP density, buprenorphine provider density, mental health shortage need-met %, Medicaid coverage breadth, 1115 SUD waiver status, and legal protections. How we score.
| Component | Detail | Points |
|---|---|---|
| OTP density | 0.309 OTPs per 100K residents | 9.3 / 30 |
| Buprenorphine density | 6.05 providers per 100K | 4.8 / 20 |
| Mental health HPSA need met | 13.25% | 4.4 / 20 |
| Medicaid breadth | 5 of 5 service categories covered | 15 / 15 |
| 1115 SUD waiver | None | 0 / 10 |
| Legal protections | Good Samaritan: No · Naloxone access: Yes | 2.5 / 5 |
| Service | Covered | Notes |
|---|---|---|
| Methadone | Yes | |
| Buprenorphine | Yes | |
| Naltrexone (Vivitrol) | Yes | |
| Outpatient SUD | Yes | |
| Residential SUD | Yes |
1115 SUD waiver: Limited (TennCare block grant/HAO waiver proposal is the relevant authority; SUD-specific IMD waiver status unclear). TennCare operates through managed care with 'in lieu of' authority potentially applicable for IMD services; standalone SUD IMD 1115 waiver not confirmed Expires TennCare II: ongoing managed care authority.